GT Metabolic Solutions Secures Series C Investment from J.P. Morgan Life Sciences Private Capital to Accelerate Global Expansion GT Metabolic™ Solutions, Inc., a medical technology company developing innovative surgical devices…
Blue Arbor Technologies Raises $10.5 Million in Series A Financing to Advance RESTORE Neuromuscular Interface System Blue Arbor Technologies, Inc., a medical technology company developing advanced neuromuscular interfaces and next-generation…
Prilenia Therapeutics and Ferrer to Present New Pridopidine Data and PREVAiLS Trial Updates at NEALS 2026 Prilenia Therapeutics B.V. and Ferrer have announced plans to present new clinical data and…
Strand Therapeutics Doses First Patients in Phase 1 Trial of STX-003, a Programmable mRNA Therapy for Solid Tumors Strand Therapeutics, a clinical-stage biotechnology company developing programmable messenger RNA (mRNA) medicines,…
Adjuvia Therapeutics Doses First Participant in Phase 1 Trial of ATI-105 for Friedreich’s Ataxia Adjuvia Therapeutics, a biotechnology company focused on developing novel treatments for mitochondrial dysfunction and associated diseases,…
LA Times Publishing Launches Journal of Breakthroughs in Medicine & Science to Advance Global Scientific Research LA Times Publishing has announced the launch of the Journal of Breakthroughs in Medicine…
Walmart Healthcare Research Institute and Care Access to Open Three New Clinical Trial Centers in 2027 Walmart Healthcare Research Institute (WHRI) and Care Access have announced plans to expand their…
Monebo Technologies and Innolitics Secure FDA 510(k) Clearance for Kinetic ECG Analysis Software Library Monebo Technologies, Inc. and Innolitics have announced that the U.S. Food and Drug Administration (FDA) has…
Arrowhead Pharmaceuticals’ REDEMPLO Gains NICE Recommendation for NHS Treatment of Familial Chylomicronaemia Syndrome in England and Wales Arrowhead Pharmaceuticals’ REDEMPLO® (plozasiran) has received a positive funding recommendation from the National…
Avanzanite Bioscience Expands UK Operations, Appoints Sarah O’Connell as Country Manager to Strengthen Rare Disease Medicine Access Avanzanite Bioscience B.V., a European pharmaceutical company specializing in rare diseases, has announced…
Laxxon Medical Appoints Matthew Cascio as Vice President and Head of Business Development to Drive Strategic Partnerships Laxxon Medical has announced the appointment of Matthew Cascio as Vice President and…
Powerful Medical Secures New CPT Code for Queen of Hearts AI ECG Technology to Detect Heart Attacks Powerful Medical, a company specializing in artificial intelligence (AI)-driven cardiovascular diagnostics, has announced…